Back to top
more

Conatus Pharmaceuticals Inc. (CNAT)

(Delayed Data from NSDQ)

$0.90 USD

0.90
746,677

+0.05 (5.88%)

Updated May 3, 2019 03:59 PM ET

After-Market: $0.90 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Allergan (AGN) Collaborates with Novartis to Treat NASH

Allergan plc (AGN) entered into a collaboration with Novartis AG (NVS) to conduct a phase IIb study to evaluate a combination of its drug cenicriviroc (cvc) and Novartis lead Fxr agonist to treat non-alcoholic steatohepatitis

    Are Options Traders Betting on a Big Move in Conatus Pharmaceuticals (CNAT) Stock?

    Conatus Pharmaceuticals (CNAT) warrants investors' attention based on moves in the options market lately.

      Conatus Pharma (CNAT) Incurs Wider-than-Expected Loss in Q4

      Conatus Pharmaceuticals Inc. (CNAT) reported fourth-quarter 2016 loss of 35 cents per share, wider than both the Zacks Consensus Estimate of a loss of 32 cents and the year-ago figure of 30 cents.

        Conatus Pharmaceuticals (CNAT) Q4 Earnings: What's in Store?

        Conatus Pharmaceuticals Inc. (CNAT) is expected to report fourth-quarter 2016 results next month.

          Henry Schein Hurt by Higher Costs, Lacks Growth Drivers

          On Jan 10, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).

            Walgreens Teams Up with Fedex to Boost Retail Performance

            Walgreens Boots Alliance, Inc. (WBA) recently inked a multi-year partnership agreement with global express delivery services company FedEx Corporation (FDX).

              NuVasive at 52-Week High on Preliminary Results, MHLW Nod

              Share price of San Diego, CA-based NuVasive, Inc. (NUVA) scaled a new 52-week high of $71.03 on Jan 11, finally closing a tad lower at $70.7.

                Can The Uptrend Continue for Conatus (CNAT)?

                Investors certainly have to be happy with Conatus Pharmaceuticals Inc. (CNAT) and its short term performance.

                  Align Poised On Global Expansion & Invisalign Teen Growth

                  On Jan 10, 2017, we issued an updated research report on California-based Align Technology Inc. (ALGN).

                    Are Options Traders Betting on a Big Move in Conatus Pharmaceuticals (CNAT) Stock?

                    Conatus Pharmaceuticals (CNAT) warrants investors' attention based on moves in the options market lately.

                      Company News for December 21, 2016

                      CNAT,GIS,BBRY,FRED

                        Conatus Stock Up on Liver Drug Collaboration with Novartis

                        Conatus (CNAT) inked an exclusive option, collaboration and license agreement with Novartis (NVS) for the worldwide development and commercialization of emricasan.